Oruka Therapeutics Inc (ORKA)

Jun 03, 2025

Oruka Therapeutics Holds Annual Stockholders Meeting - TipRanks

Jun 03, 2025

Jun 02, 2025

Jane Street Group LLC Buys New Shares in Oruka Therapeutics, Inc. (NASDAQ:ORKA) - Defense World

Jun 02, 2025

May 30, 2025

HC Wainwright Has Positive Estimate for ORKA Q2 Earnings - Defense World

May 30, 2025

May 29, 2025

Northern Trust Corp Acquires Shares of 64,044 Oruka Therapeutics, Inc. (NASDAQ:ORKA) - Defense World

May 29, 2025

May 28, 2025

H.C. Wainwright Maintains Buy Rating on Oruka (ORKA) After the Early Start of OKRA-002 Trial - MSN

May 28, 2025

May 27, 2025

H.C. Wainwright maintains Buy on Oruka stock, $45 target By Investing.com - Investing.com India

May 27, 2025

May 27, 2025

H.C. Wainwright maintains Buy on Oruka stock, $45 target - Investing.com UK

May 27, 2025

May 26, 2025

Oruka Therapeutics, Inc. (NASDAQ:ORKA) Given Consensus Recommendation of “Buy” by Analysts - Defense World

May 26, 2025

May 25, 2025

Oruka Therapeutics (NASDAQ:ORKA) Upgraded at BTIG Research - Defense World

May 25, 2025

May 22, 2025

BTIG Initiates Oruka Therapeutics at Buy With $44 Price Target - marketscreener.com

May 22, 2025

May 22, 2025

BTIG sets $44 price target on Oruka Therapeutics stock - Investing.com UK

May 22, 2025

May 21, 2025

Oruka Therapeutics to Present at the Jefferies Global Healthcare Conference - GlobeNewswire

May 21, 2025

May 20, 2025

Oruka Therapeutics begins trial for psoriasis treatment By Investing.com - Investing.com South Africa

May 20, 2025

May 20, 2025

Oruka Therapeutics begins trial for psoriasis treatment - Investing.com Australia

May 20, 2025

May 20, 2025

Oruka Therapeutics Begins Dosing in Phase 1 Trial of ORKA-002 for Skin Disease Treatment - marketscreener.com

May 20, 2025

May 20, 2025

Oruka Therapeutics Announces First Participants Dosed in Phase 1 Trial of ORKA-002, its Novel Half-life Extended Anti-IL-17A/F Antibody - GlobeNewswire

May 20, 2025

May 20, 2025

Revolutionary Psoriasis Treatment Begins Human Trials: Only 2-3 Doses Per Year Needed - Stock Titan

May 20, 2025

May 19, 2025

Wedbush Forecasts Reduced Earnings for Oruka Therapeutics - Defense World

May 19, 2025

May 18, 2025

What is Wedbush’s Estimate for ORKA FY2029 Earnings? - Defense World

May 18, 2025

May 17, 2025

Wedbush Reaffirms “Outperform” Rating for Oruka Therapeutics (NASDAQ:ORKA) - Defense World

May 17, 2025

May 17, 2025

Oruka Therapeutics (NASDAQ:ORKA) versus Trinity Biotech (NASDAQ:TRIB) Critical Analysis - Defense World

May 17, 2025

May 14, 2025

Oruka Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Update - The Manila Times

May 14, 2025

May 14, 2025

Oruka Therapeutics Announces Accelerated Clinical Timelines and Strong Financial Position for Psoriasis Programs - Nasdaq

May 14, 2025

May 14, 2025

Oruka Therapeutics Reports First Quarter 2025 Financial Results And Provides Corporate Update - marketscreener.com

May 14, 2025

May 14, 2025

Oruka Therapeutics, Inc. SEC 10-Q Report - TradingView

May 14, 2025

May 12, 2025

Oruka Therapeutics (NASDAQ:ORKA) and Trinity Biotech (NASDAQ:TRIB) Head-To-Head Analysis - Defense World

May 12, 2025

May 07, 2025

JPMorgan Chase & Co. Acquires New Position in Oruka Therapeutics, Inc. (NASDAQ:ORKA) - Defense World

May 07, 2025

May 04, 2025

Barclays PLC Purchases Shares of 74,583 Oruka Therapeutics, Inc. (NASDAQ:ORKA) - Defense World

May 04, 2025

May 02, 2025

HC Wainwright Issues Negative Estimate for ORKA Earnings - Defense World

May 02, 2025

May 01, 2025

Equities Analysts Offer Predictions for ORKA Q1 Earnings - Defense World

May 01, 2025

Apr 29, 2025

Oruka Therapeutics to Present at Bank of America Securities 2025 Health Care Conference - GlobeNewswire

Apr 29, 2025

Apr 26, 2025

Geode Capital Management LLC Boosts Stock Position in Oruka Therapeutics, Inc. (NASDAQ:ORKA) - Defense World

Apr 26, 2025

Apr 26, 2025

Comparing TNF Pharmaceuticals (NASDAQ:TNFA) & Oruka Therapeutics (NASDAQ:ORKA) - Defense World

Apr 26, 2025

Apr 21, 2025

Oruka Therapeutics Inc expected to post a loss of 52 cents a shareEarnings Preview - TradingView

Apr 21, 2025

Apr 17, 2025

Oruka Therapeutics (ORKA) Projected to Post Quarterly Earnings on Thursday - Defense World

Apr 17, 2025

Apr 15, 2025

Vanguard Group Inc. Purchases 1,572,853 Shares of Oruka Therapeutics, Inc. (NASDAQ:ORKA) - The AM Reporter

Apr 15, 2025

Apr 15, 2025

Vanguard Group Inc. Acquires 1,572,853 Shares of Oruka Therapeutics, Inc. (NASDAQ:ORKA) - Defense World

Apr 15, 2025

Apr 13, 2025

Oruka Therapeutics, Inc. (NASDAQ:ORKA) Shares Acquired by Wellington Management Group LLP - Defense World

Apr 13, 2025

Apr 06, 2025

Oruka Therapeutics, Inc. (NASDAQ:ORKA) Receives Consensus Rating of “Buy” from Analysts - Defense World

Apr 06, 2025

Apr 02, 2025

Charles Schwab Investment Management Inc. Takes Position in Oruka Therapeutics, Inc. (NASDAQ:ORKA) - Defense World

Apr 02, 2025

Mar 24, 2025

Contrasting Achieve Life Sciences (NASDAQ:ACHV) & Oruka Therapeutics (NASDAQ:ORKA) - Defense World

Mar 24, 2025

Mar 21, 2025

Fairmount Funds Management LLC Increases Stake in Oruka Therapeu - GuruFocus

Mar 21, 2025

Mar 17, 2025

Oruka Therapeutics Reports Strong 2024 Financial Results - TipRanks

Mar 17, 2025

Mar 11, 2025

Oruka Therapeutics at Risk: Navigating Licensing Challenges and Partner Reliance - MSN

Mar 11, 2025

Mar 11, 2025

Comparing Oruka Therapeutics (NASDAQ:ORKA) & Celldex Therapeutics (NASDAQ:CLDX) - Defense World

Mar 11, 2025

Mar 10, 2025

Oruka Therapeutics (NASDAQ:ORKA) Issues Earnings Results - MarketBeat

Mar 10, 2025

Mar 09, 2025

Oruka Therapeutics (NASDAQ:ORKA) Earns “Outperform” Rating from Wedbush - Defense World

Mar 09, 2025

Mar 08, 2025

We're Not Very Worried About Oruka Therapeutics' (NASDAQ:ORKA) Cash Burn Rate - Yahoo Finance

Mar 08, 2025